piglets(@piglets71753527) 's Twitter Profile Photo

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkerman vision drives our AI-powered approach to develop targeted therapies for various conditions.

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkerman vision drives our AI-powered approach to develop targeted therapies for various conditions. #PrecisionTherapies #NicoleJunkermann
account_circle
Bethanie Pick(@BethaniePi45392) 's Twitter Profile Photo

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkermann's vision drives our AI-powered approach to develop targeted therapies for various conditions.

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkermann's vision drives our AI-powered approach to develop targeted therapies for various conditions. #PrecisionTherapies
account_circle
Arla Otter(@ArlaO30816) 's Twitter Profile Photo

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkermann's vision drives our AI-powered approach to develop targeted therapies for various conditions.

🎯 Precision meets potential at Alto Neuroscience! Nicole Junkermann's vision drives our AI-powered approach to develop targeted therapies for various conditions. #PrecisionTherapies
account_circle
Peter Mundel, MD(@PeterMundel) 's Twitter Profile Photo

Representing ⁦@goldfinchbio⁩ and collaborators with “The Kidney Genome Atlas: a comprehensive whole genome and transcriptome landscape of proteinuric kidney diseases” ⁦World Congress of Nephrology⁩ ⁦This is our cornerstone, the future of for

Representing ⁦@goldfinchbio⁩ and collaborators with “The Kidney Genome Atlas: a comprehensive whole genome and transcriptome landscape of proteinuric kidney diseases” ⁦@ISNWCN⁩ ⁦This is our cornerstone, the future of #precisiontherapies for #kidneydiseases
account_circle
ETP Nanomedicine(@etpnanomedicine) 's Twitter Profile Photo

Two new members join the ETPN today! bit.ly/2tbwS1A
V-Nano (NanoGold member): a contract development and organization for based in France & the Faculty of Pharmacy of Helsinki WELCOME ON BOARD!

Two new members join the ETPN today! bit.ly/2tbwS1A
V-Nano (NanoGold member): a contract development and #manufacturing organization #CDMO for #precisiontherapies based in France & the Faculty of Pharmacy of Helsinki WELCOME ON BOARD!
#nanomedicine #Europe #SME #academia
account_circle
Second Genome(@SecondGenome) 's Twitter Profile Photo

We're moving our pipeline of and biomarkers for healing and closer to the clinic. Learn about our unique approach in our Jefferies Therapeutics Summit fireside chat: bit.ly/2RPYIw1

We're moving our pipeline of #precisiontherapies and biomarkers for #mucosal healing and #immunooncology closer to the clinic. Learn about our unique approach in our @Jefferies #Microbiome Therapeutics Summit fireside chat: bit.ly/2RPYIw1
account_circle
Blueprint Medicines(@BlueprintMeds) 's Twitter Profile Photo

At Blueprint, we aim to develop that transform patient care and stay one step ahead of disease. Learn more about what we do: bit.ly/316kKNZ

At Blueprint, we aim to develop #precisiontherapies that transform patient care and stay one step ahead of disease. Learn more about what we do: bit.ly/316kKNZ
account_circle
INFRAFRONTIER(@InfrafrontierEU) 's Twitter Profile Photo

The FORUM Translational Medicine bit.ly/2DrhRuW on Nov 29, 2018 focuses on the translational process of biomedical science, and . It will present highlights in research & development from academia, clinic, and industry.

The FORUM Translational Medicine bit.ly/2DrhRuW  on Nov 29, 2018 focuses on the translational process of biomedical science, #clinicalresearch and #precisiontherapies. It will  present highlights in research & development from academia, clinic, and industry.
account_circle
New York Stem Cell Foundation Research Institute(@nyscf) 's Twitter Profile Photo

Join our panel of experts as they discuss gender in cancer outcomes, and how the latest advances in cancer and are advancing hope, , & for women with .
Save your seat: bit.ly/3HA5rhM

Join our panel of experts as they discuss gender #healthdisparities in cancer outcomes, and how the latest advances in cancer and #stemcellresearch are advancing hope, #equity, & #precisiontherapies for women with #reproductivecancers. 
Save your seat: bit.ly/3HA5rhM
account_circle
TickerBay(@BayTicker7390) 's Twitter Profile Photo

$COGT Cogent Biosciences will present initial results from the Phase 2 clinical study of bezuclastinib for NonAdvanced Systemic Mastocytosis at the 2024 AAAAI Annual Meeting. Stay tuned for more updates!

account_circle